JANINNE ABEL: Open Payments
NPI 1427359843 · COVINGTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$649 in 31 payments from 18 companies in 2025. Trend: 2023 $68 · 2024 $432 · 2025 $649
Food & beverage: $649
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $79 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $67 |
| Amgen Inc. | 4 | $67 |
| Phathom Pharmaceuticals, Inc. | 1 | $62 |
| Lilly USA, LLC | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Esperion Therapeutics, Inc. | 2 | $48 |
| Boston Scientific Corporation | 1 | $38 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| PFIZER INC. | 1 | $20 |
Products named: JARDIANCE, KRYSTEXXA, VOQUEZNA, MOUNJARO, NEXLETOL, Wegovy, General - Pain Management, AIRSUPRA.
Industry payments across GA — which companies pay providers there.
